Lei Hong

Lei Hong currently serves as Senior Director - CMC Regulatory at REVOLUTION Medicines since May 2023. Prior experience includes roles at Corcept Therapeutics, where Lei held positions from Sr. Manager to Director of Regulatory Affairs over five years, and at Gilead Sciences, progressing from Associate Scientist to Associate Manager in Regulatory Affairs CMC. Earlier in the career, Lei was a Research Associate at Roche for seven years. Educational qualifications include a Master of Science in Pharmaceutical Sciences from the University of Missouri-Kansas City and a Bachelor of Science in Pharmaceutical Sciences from China Pharmaceutical University.